Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the directors' interests in the Ordinary shares and American Depository Shares (ADSs) of GlaxoSmithKline plc.
On 30 June 2008, the Company's Non-Executive Directors were provisionally allocated the following awards over Ordinary shares at a price of £11.18 per share and ADSs at a price of $44.17 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 April 2008 to 30 June 2008:
Non Executive Director |
Ordinary Shares |
American Depository Shares (ADSs) |
Sir Christopher Gent |
3,018.78 |
|
Prof. Sir Roy Anderson |
698.79 |
|
Dr Stephanie Burns |
|
535.49 |
Mr Lawrence Culp |
|
1,070.98 |
Sir Crispin Davis |
2,124.33 |
|
Sir Deryck Maughan |
|
1,070.98 |
Dr Daniel Podolsky |
|
704.59 |
Sir Ian Prosser |
1,173.97 |
|
Dr Ronaldo Schmitz |
849.73 |
|
Mr Tom de Swaan |
698.79 |
|
Sir Robert Wilson |
642.89 |
|
The Company and the Non-Executive Directors were informed of these allocations on 1 July 2008.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
S M Bicknell
Company Secretary
1 July 2008